160 related articles for article (PubMed ID: 21867600)
1. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
2. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NF-κB signaling by the A20 deubiquitinase.
Shembade N; Harhaj EW
Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
[TBL] [Abstract][Full Text] [Related]
4. A20: central gatekeeper in inflammation and immunity.
Coornaert B; Carpentier I; Beyaert R
J Biol Chem; 2009 Mar; 284(13):8217-21. PubMed ID: 19008218
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
6. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation.
Lutz J; Luong le A; Strobl M; Deng M; Huang H; Anton M; Zakkar M; Enesa K; Chaudhury H; Haskard DO; Baumann M; Boyle J; Harten S; Maxwell PH; Pusey C; Heemann U; Evans PC
J Mol Med (Berl); 2008 Dec; 86(12):1329-39. PubMed ID: 18813897
[TBL] [Abstract][Full Text] [Related]
7. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
8. A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.
Igarashi H; Yahagi A; Saika T; Hashimoto J; Tomita T; Yoshikawa H; Ishihara K
Immunol Lett; 2012 Jan; 141(2):246-53. PubMed ID: 22093807
[TBL] [Abstract][Full Text] [Related]
9. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
10. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
11. Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.
Altonsy MO; Sasse SK; Phang TL; Gerber AN
J Biol Chem; 2014 Mar; 289(12):8231-9. PubMed ID: 24500711
[TBL] [Abstract][Full Text] [Related]
12. Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA.
Zhang X; Dong C; Sun X; Li Z; Zhang M; Guan Z; Duan M
Biochem Biophys Res Commun; 2014 Jul; 450(1):755-61. PubMed ID: 24953694
[TBL] [Abstract][Full Text] [Related]
13. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
Vereecke L; Beyaert R; van Loo G
Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
[TBL] [Abstract][Full Text] [Related]
14. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
[TBL] [Abstract][Full Text] [Related]
15. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
Ma A; Malynn BA
Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
[TBL] [Abstract][Full Text] [Related]
16. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
[TBL] [Abstract][Full Text] [Related]
17. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.
Frenzel LP; Claus R; Plume N; Schwamb J; Konermann C; Pallasch CP; Claasen J; Brinker R; Wollnik B; Plass C; Wendtner CM
Int J Cancer; 2011 May; 128(10):2495-500. PubMed ID: 20669229
[TBL] [Abstract][Full Text] [Related]
18. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
19. Functional dichotomy of A20 in apoptotic and necrotic cell death.
Storz P; Döppler H; Ferran C; Grey ST; Toker A
Biochem J; 2005 Apr; 387(Pt 1):47-55. PubMed ID: 15527421
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
